Spotlight on the human factor: building a foundation for the future of haemophilia A management: report from a symposium on human recombinant FVIII at the World Federation of Hemophilia World Congress, Melbourne, Australia on 12 May 2014.
about
Biological therapies for inherited diseases: social and bioethical considerations. Hemophilia as an example.Immunogenicity, efficacy and safety of Nuwiq(®) (human-cl rhFVIII) in previously untreated patients with severe haemophilia A-Interim results from the NuProtect Study.Comparative N-Glycosylation Analysis of the Fc Portions of a Chimeric Human Coagulation Factor VIII and Immunoglobulin G1Simoctocog alfa for the treatment of hemophilia A.Recombinant Proteins and Monoclonal Antibodies.
P2860
Spotlight on the human factor: building a foundation for the future of haemophilia A management: report from a symposium on human recombinant FVIII at the World Federation of Hemophilia World Congress, Melbourne, Australia on 12 May 2014.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Spotlight on the human factor: ...... rne, Australia on 12 May 2014.
@en
type
label
Spotlight on the human factor: ...... rne, Australia on 12 May 2014.
@en
prefLabel
Spotlight on the human factor: ...... rne, Australia on 12 May 2014.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Spotlight on the human factor: ...... urne, Australia on 12 May 2014
@en
P2093
C Escuriola Ettingshausen
J Oldenburg
R Klamroth
P2860
P356
10.1111/HAE.12582
P478
21 Suppl 1
P577
2015-01-01T00:00:00Z